Related Experiment Videos
The contingent valuation method in health care
1Department of Health Economics, University of Ulm, Germany.
Health Policy (Amsterdam, Netherlands)
|October 28, 1999
Summary
The contingent valuation method (CVM) shows theoretical validity for valuing health technologies, but methodological issues like elicitation formats and biases hinder its use. Further research is needed before CVM can inform healthcare decisions.
Area of Science:
- Health Economics
- Health Technology Assessment
- Survey Methodology
Background:
- The contingent valuation method (CVM) is a survey-based approach to assign monetary values to health technology benefits.
- Willingness to pay (WTP) is a key metric in CVM, often compared to other benefit measures in medical technology assessment.
- Existing literature reviews highlight significant methodological and conceptual challenges associated with CVM in healthcare.
Purpose of the Study:
- To comprehensively review the methodological and conceptual issues of the contingent valuation method (CVM) in the health care literature.
- To assess the validity and reliability of CVM as a tool for determining monetary valuations of health technology effects.
- To identify areas for further research to improve the application of CVM in healthcare decision-making.
Main Methods:
- Systematic review of studies published before 1998, identified through computerized databases and previous reviews.
- Inclusion criteria focused on studies using original data and meeting qualitative standards for CVM application.
- Analysis of methodological aspects including elicitation formats, validity (theoretical, convergent, criterion), reliability, and potential biases (starting point, range, strategic).
Main Results:
- CVM demonstrated sufficient theoretical validity and indications of convergent validity, but criterion validity and reliability remain under-investigated.
- Widespread use of diverse elicitation formats complicates study comparisons; direct questions and starting point bias in bidding games were identified as problematic.
- Range bias in payment cards was suggested, but no strategic bias was found. Limited investigation into valuation states and payment methods.
- Influence of valuation states (ex-ante, ex-post) and respondent status (diseased/non-diseased) requires further study.
Conclusions:
- While CVM shows theoretical promise for valuing health technologies, significant methodological and conceptual issues require further investigation.
- Addressing elicitation biases, improving reliability testing, and exploring valuation states are crucial before CVM can be reliably used in healthcare decision-making.
- Further research should focus on criterion validity, reliability assessments, and understanding the impact of different evaluation contexts and respondent characteristics.